L P Oe - JoVE Visualize

Showing results (11-20 of 18) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 18 results.

Haematologica|July 1, 1995

Does additional treatment with fish oil mitigate the side effects of recombinant human erythropoietin in dialysis patients?C W de Fijter, C Popp-Snijders, L P Oe, et al.

Kidney International|October 1, 1992

Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysisC W de Fijter, H A Verbrugh, L P Oe, et al.

Nephron|January 1, 1991

Short dwell times reduce the local defence mechanism of chronic peritoneal dialysis patientsK Vlaanderen, H J Bos, C W de Fijter, et al.

Annals of Internal Medicine|February 15, 1994

Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysisC W de Fijter, L P Oe, J J Nauta, et al.

ASAIO Transactions|October 1, 1990

The influence of dialysate sodium and variable ultrafiltration on fluid balance during hemodialysisP M de Vries, P M Kouw, C G Olthof, et al.

American Heart Journal|December 1, 1988

Doxazosin in the treatment of patients with mild or moderate hypertension and mild or moderate renal insufficiencyA C Bartels, P M de Vries, L P Oe, et al.

Kidney International|October 1, 1993

Non-invasive monitoring of blood volume during hemodialysis: its relation with post-dialytic dry weightJ P de Vries, P M Kouw, N J van der Meer, et al.

The American Journal of Clinical Nutrition|February 1, 1991

Adipose tissue fatty acid composition and its relations to diet and plasma lipid concentrations in hemodialysis patientsP M de Vries, H B Folkers, C W de Fijter, et al.

Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 18 results.

Haematologica|July 1, 1995

Does additional treatment with fish oil mitigate the side effects of recombinant human erythropoietin in dialysis patients?C W de Fijter, C Popp-Snijders, L P Oe, et al.

Kidney International|October 1, 1992

Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysisC W de Fijter, H A Verbrugh, L P Oe, et al.

Nephron|January 1, 1991

Short dwell times reduce the local defence mechanism of chronic peritoneal dialysis patientsK Vlaanderen, H J Bos, C W de Fijter, et al.

Annals of Internal Medicine|February 15, 1994

Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysisC W de Fijter, L P Oe, J J Nauta, et al.

ASAIO Transactions|October 1, 1990

The influence of dialysate sodium and variable ultrafiltration on fluid balance during hemodialysisP M de Vries, P M Kouw, C G Olthof, et al.

American Heart Journal|December 1, 1988

Doxazosin in the treatment of patients with mild or moderate hypertension and mild or moderate renal insufficiencyA C Bartels, P M de Vries, L P Oe, et al.

Kidney International|October 1, 1993

Non-invasive monitoring of blood volume during hemodialysis: its relation with post-dialytic dry weightJ P de Vries, P M Kouw, N J van der Meer, et al.

The American Journal of Clinical Nutrition|February 1, 1991

Adipose tissue fatty acid composition and its relations to diet and plasma lipid concentrations in hemodialysis patientsP M de Vries, H B Folkers, C W de Fijter, et al.

Pageof 2